La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Elevance Health Gestione
Gestione criteri di controllo 3/4
Elevance Health's Il CEO è Gail Boudreaux, nominato in Nov2017, e ha un mandato di 6.75 anni. la retribuzione annua totale è $ 21.89M, composta da 7.3% di stipendio e 92.7% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.047% delle azioni della società, per un valore di $ 59.74M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 6.5 anni e 11 anni.
Informazioni chiave
Gail Boudreaux
Amministratore delegato
US$21.9m
Compenso totale
| Percentuale dello stipendio del CEO | 7.3% |
| Mandato del CEO | 6.8yrs |
| Proprietà del CEO | 0.05% |
| Durata media del management | 6.6yrs |
| Durata media del Consiglio di amministrazione | 11.1yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)
Sep 11
Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth
Sep 06There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital
Aug 29Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Elevance Health: Healthcare Services Segment Is Gaining Traction
Jul 31Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48
Feb 17Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Feb 13Elevance Health: Attractive On Its Expansion Catalysts
Feb 09Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48
Jan 28Elevance Health acquiring Blue Cross and Blue Shield of Louisiana
Jan 23Elevance Health Offers Great Value
Jan 17At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?
Jan 17Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name
Jan 02Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$7b |
| Mar 31 2024 | n/a | n/a | US$6b |
| Dec 31 2023 | US$22m | US$2m | US$6b |
| Sep 30 2023 | n/a | n/a | US$6b |
| Jun 30 2023 | n/a | n/a | US$6b |
| Mar 31 2023 | n/a | n/a | US$6b |
| Dec 31 2022 | US$21m | US$2m | US$6b |
| Sep 30 2022 | n/a | n/a | US$6b |
| Jun 30 2022 | n/a | n/a | US$6b |
| Mar 31 2022 | n/a | n/a | US$6b |
| Dec 31 2021 | US$19m | US$2m | US$6b |
| Sep 30 2021 | n/a | n/a | US$6b |
| Jun 30 2021 | n/a | n/a | US$4b |
| Mar 31 2021 | n/a | n/a | US$5b |
| Dec 31 2020 | US$17m | US$1m | US$5b |
| Sep 30 2020 | n/a | n/a | US$5b |
| Jun 30 2020 | n/a | n/a | US$6b |
| Mar 31 2020 | n/a | n/a | US$5b |
| Dec 31 2019 | US$15m | US$1m | US$5b |
| Sep 30 2019 | n/a | n/a | US$4b |
| Jun 30 2019 | n/a | n/a | US$4b |
| Mar 31 2019 | n/a | n/a | US$4b |
| Dec 31 2018 | US$14m | US$1m | US$4b |
| Sep 30 2018 | n/a | n/a | US$5b |
| Jun 30 2018 | n/a | n/a | US$4b |
| Mar 31 2018 | n/a | n/a | US$4b |
| Dec 31 2017 | US$3m | US$162k | US$4b |
Compensazione vs Mercato: La retribuzione totale di Gail ($USD 21.89M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 13.17M ).
Compensazione vs guadagni: La retribuzione di Gail è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Gail Boudreaux (63 yo)
6.8yrs
Mandato
US$21,889,039
Compensazione
Ms. Gail Koziara Boudreaux has been an Independent Director at Target Corporation since September 23, 2021. She has been President, Chief Executive Officer and Director of Elevance Health Inc. (formerly kn...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 6.8yrs | US$21.89m | 0.047% $ 57.6m | |
| Executive VP & CFO | less than a year | US$12.36m | Nessun dato | |
| Executive VP and Chief Legal & Administrative Officer | 3.8yrs | US$8.11m | 0.0044% $ 5.4m | |
| Executive VP and President of Carelon & CarelonRx | 10.3yrs | US$6.98m | 0.0063% $ 7.6m | |
| Executive VP & President of Government Health Benefits | 6.3yrs | US$6.48m | 0.0098% $ 11.9m | |
| SVP, Treasurer & Chief Investment Officer | 6.4yrs | Nessun dato | Nessun dato | |
| Senior VP | 8.8yrs | Nessun dato | 0.00057% $ 692.5k | |
| Vice President of Investor Relations | no data | Nessun dato | Nessun dato | |
| Senior Vice President of Public Affairs | 10.8yrs | Nessun dato | Nessun dato | |
| Chief Strategy Officer & Interim Chief Marketing Officer | less than a year | Nessun dato | Nessun dato | |
| Executive VP and President of Commercial & Specialty Health Benefits | no data | Nessun dato | 0.0050% $ 6.0m | |
| President of Dental Business | 7.8yrs | Nessun dato | Nessun dato |
6.6yrs
Durata media
58yo
Età media
Gestione esperta: Il team dirigenziale di ELV è esperto e expertise (durata media dell'incarico 6.5 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 6.8yrs | US$21.89m | 0.047% $ 57.6m | |
| Independent Director | 19.8yrs | US$386.76k | 0.0024% $ 2.9m | |
| Independent Chair of the Board | 10.9yrs | US$597.83k | Nessun dato | |
| Independent Director | 11.2yrs | US$362.53k | Nessun dato | |
| Independent Director | 6.6yrs | US$371.42k | Nessun dato | |
| Independent Director | 10.3yrs | US$371.42k | Nessun dato | |
| Independent Director | 4.9yrs | US$347.28k | 0.0013% $ 1.6m | |
| Independent Director | 13.2yrs | US$360.34k | 0.0031% $ 3.8m | |
| Member of Advisory Board | 11.1yrs | Nessun dato | Nessun dato | |
| Member of Advisory Board | 11.1yrs | Nessun dato | Nessun dato | |
| Member of Advisory Board | 11.1yrs | Nessun dato | Nessun dato | |
| Member of Advisory Board | 11.1yrs | Nessun dato | Nessun dato |
11.1yrs
Durata media
68yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di ELV è composto da personale esperto e esperto (durata media dell'incarico 11 anni).